<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Congenital disorders of glycosylation affecting multiple pathways</title><link href="/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/d/css/icofont.min.css" rel="stylesheet"/><link href="/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/d/css/animate.css" rel="stylesheet"/><link href="/d/css/owl.carousel.css" rel="stylesheet"/><link href="/d/css/magnific-popup.css" rel="stylesheet"/><link href="/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/d/css/style.css" rel="stylesheet"/><link href="/d/css/rtl_edited.css" rel="stylesheet"/><link href="/d/css/responsive.css" rel="stylesheet"/><link href="https://medilib.ir/uptodate_assets/main.css" rel="stylesheet">
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>

<meta content="" name="description"/>
<link href="/d/img/favicon.png" rel="icon" type="image/png"/>
</link></head>
<body>
<!-- Start Main Menu Area -->

<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>




<section class="teacher-area ptb-10">
<div class="container">
</div>

<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Congenital disorders of glycosylation affecting multiple pathways</h1>
<div class="graphic"><div class="figure"><div class="ttl">Congenital disorders of glycosylation affecting multiple pathways</div><div class="cntnt"><table cellspacing="0"><colgroup span="7" width="14%"></colgroup> <tbody> <tr> <td class="subtitle1_left">Gene</td> <td class="subtitle1_left">Gene locus MIM#</td> <td class="subtitle1_left">Function</td> <td class="subtitle1_left">Localization of defect</td> <td class="subtitle1_left">Disease</td> <td class="subtitle1_left">Inheritance</td> <td class="subtitle1_left">Initial molecular characterization (PMID)</td> </tr> <tr> <td class="subtitle2_left" colspan="7">Monosaccharide synthesis</td> </tr> <tr> <td class="indent1">Glutamine-fructose-6-phosphate transaminase 1 (<em>GFPT1</em>)</td> <td>138292</td> <td>Glutamine:F6P amidotransferase (converts F6P to GlcN-6P for UDP-GlcNAc synthesis)</td> <td>Cytosol</td> <td>CMS12</td> <td>AR</td> <td>21310273</td> </tr> <tr> <td class="indent1">Glucosamine (UDP-N-acetyl)-2-epimerase/N-acetylmannosamine kinase (<em>GNE</em>)</td> <td>603824</td> <td>UDP-GlcNAc 2-epimerase/ManNAc kinase (converts UDP-GlcNAc to ManNAc and then to ManNac-6P)</td> <td>Cytosol</td> <td>GNE myopathy, sialuria</td> <td>AR, AD</td> <td>11528398, 10330343</td> </tr> <tr> <td class="indent1">N-acetylneuraminate synthase (<em>NANS</em>)</td> <td>605202</td> <td>Converts ManNac-6P to Neu5Ac-9P</td> <td>Cytosol</td> <td>SEMD, Camera-Genevieve type</td> <td>AR</td> <td>27213289</td> </tr> <tr> <td class="indent1">N-acetylneuraminate pyruvate lyase (<em>NPL</em>)</td> <td>611412</td> <td>Recycles sialic acid to ManNAc</td> <td>Cytosol</td> <td>N-acetylneuraminate pyruvate lyase deficiency</td> <td>AR</td> <td>30568043</td> </tr> <tr> <td class="subtitle2_left" colspan="7">Monosaccharide interconversion</td> </tr> <tr> <td class="indent1">Phosphoglucomutase 1 (<em>PGM1</em>)</td> <td>612934</td> <td>Phosphoglucomutase (reversible conversion of Glc-1P to Glc-6P)</td> <td>Cytosol</td> <td>PGM1-CDG (CDG-It)</td> <td>AR</td> <td>19625727</td> </tr> <tr> <td class="indent1">Glucosamine-phosphate N-acetyltransferase 1 (<em>GNPNAT1</em>)</td> <td>616510</td> <td>Glucosamine-phosphate N-acetyltransferase (converts GlcN-6P to GlcNAc-6P)</td> <td>Cytosol</td> <td>GNPNAT1-CDG</td> <td>AR</td> <td>32591345</td> </tr> <tr> <td class="indent1">Phosphoglucomutase 3 (<em>PGM3</em>)</td> <td>172100</td> <td>Reversible conversion of GlcNAc-6P to GlcNAc-1P</td> <td>Cytosol</td> <td>Immunodeficiency 23</td> <td>AR</td> <td>24589341, 24698316, 24931394</td> </tr> <tr> <td class="indent1">Glucose-6-phosphatase catalytic subunit 3 (<em>G6PC3</em>)</td> <td>611045</td> <td>Glucose-6-phosphatase (Glc-6P to Glc)</td> <td>ER</td> <td>Severe congenital neutropenia 4</td> <td>AR</td> <td>19118303</td> </tr> <tr> <td class="subtitle2_left" colspan="7">Dolichol biosynthesis</td> </tr> <tr> <td class="indent1">Dehydrodolichyl diphosphate synthase subunit (<em>DHDDS</em>)</td> <td>608172</td> <td>Cis-isoprenyl transferase</td> <td>ER (cytosolic side)</td> <td>Retinitis pigmentosa 59</td> <td>AR, AD</td> <td>21295283</td> </tr> <tr> <td class="indent1">NUS1 dehydrodolichyl diphosphate synthase subunit (<em>NUS1</em>)</td> <td>610463</td> <td>Stabilizes cis-isoprenyl transferase</td> <td>ER</td> <td>NUS1-CDG (CDG-Iaa)</td> <td>AR, AD</td> <td>25066056</td> </tr> <tr> <td class="indent1">Steroid 5 alpha-reductase 3 (<em>SRD5A3</em>)</td> <td>611715</td> <td>Polyprenol reductase</td> <td>ER</td> <td>SRD5A3-CDG (CDG-Iq)</td> <td>AR</td> <td>20637498</td> </tr> <tr> <td class="indent1">Dolichol kinase (<em>DOLK</em>)</td> <td>610746</td> <td>Dolichol kinase</td> <td>ER</td> <td>DOLK-CDG (CDG-Im)</td> <td>AR</td> <td>17273964</td> </tr> <tr> <td class="subtitle2_left" colspan="7">Dolichol-P-sugar biosynthesis and utilization</td> </tr> <tr> <td class="indent1">Dolichyl-phosphate mannosyltransferase subunit 1, catalytic (<em>DPM1</em>)</td> <td>603503</td> <td>Dol-P-Man synthase</td> <td>ER (cytosolic side)</td> <td>DPM1-CDG (CDG-Ie)</td> <td>AR</td> <td>10642597, 10642602</td> </tr> <tr> <td class="indent1">Dolichyl-phosphate mannosyltransferase subunit 2, regulatory (<em>DPM2</em>)</td> <td>603564</td> <td>Dol-P-Man synthase</td> <td>ER</td> <td>DPM2-CDG (CDG-Iu)</td> <td>AR</td> <td>23109149</td> </tr> <tr> <td class="indent1">Dolichyl-phosphate mannosyltransferase subunit 3, regulatory (<em>DPM3</em>)</td> <td>605951</td> <td>Dol-P-Man synthase</td> <td>ER</td> <td>DPM3-CDG (CDG-Io)</td> <td>AR</td> <td>19576565</td> </tr> <tr> <td class="indent1">Mannose-P-dolichol utilization defect 1 (<em>MPDU1</em>)</td> <td>604041</td> <td>Dol-P-sugar availability</td> <td>ER</td> <td>MPDU1-CDG (CDG-If)</td> <td>AR</td> <td>11733564</td> </tr> <tr> <td class="subtitle2_left" colspan="7">Nucleotide-sugar synthesis and interconversion</td> </tr> <tr> <td class="indent1">Carbamoyl-phosphate synthetase 2, aspartate transcarbamylase, and dihydroorotase (<em>CAD</em>)</td> <td>114010</td> <td>First 3 enzymes in pyrimidine biosynthesis</td> <td>Cytosol</td> <td>CAD-CDG (CDG-Iz, EIEE50)</td> <td>AR</td> <td>25678555</td> </tr> <tr> <td class="indent1">GDP-mannose pyrophosphorylase A (<em>GMPPA</em>)</td> <td>615495</td> <td>Regulatory role or GMPPB</td> <td>Cytosol</td> <td>Intellectual disability, alacrima, and achalasia syndrome</td> <td>AR</td> <td>24035193</td> </tr> <tr> <td class="indent1">GDP-mannose pyrophosphorylase B (<em>GMPPB</em>)</td> <td>615320</td> <td>Synthesizes GDP-mannose from Man-1P and GTP</td> <td>Cytosol</td> <td>MDDGA14, MDDGB14, MDDGC14</td> <td>AR</td> <td>23768512</td> </tr> <tr> <td class="indent1">UDP-glucose pyrophosphorylase 2 (<em>UGP2</em>)</td> <td>191760</td> <td>UDP-Glc pyrophosphorylase 2 (converts Glc-1P to UDP-Glc)</td> <td>Cytosol</td> <td>UGP2-CDG</td> <td>AR</td> <td>31820119</td> </tr> <tr> <td class="indent1">UDP-glucose 6-dehydrogenase (<em>UGDH</em>)</td> <td>603370</td> <td>UDP-Glc dehydrogenase (converts UDP-Glc to UDP-GlcA)</td> <td>Cytosol</td> <td>UGDH-CDG</td> <td>AR</td> <td>32001716</td> </tr> <tr> <td class="subtitle2_left" colspan="7">Transporters</td> </tr> <tr> <td class="indent1">Solute carrier family 10 member 7 (<em>SLC10A7</em>)</td> <td>611459</td> <td>Calcium transport</td> <td>Plasma membrane</td> <td>SLC10A7-CDG</td> <td>AR</td> <td>30082715</td> </tr> <tr> <td class="indent1">Solute carrier family 35 member A1 (<em>SLC35A1</em>)</td> <td>605634</td> <td>CMP-Sia transport</td> <td>Golgi</td> <td>SLC35A1-CDG (CDG-IIf)</td> <td>AR</td> <td>15576474</td> </tr> <tr> <td class="indent1">Solute carrier family 35 member A2 (<em>SLC35A2</em>)</td> <td>314375</td> <td>UDP-galactose transport</td> <td>Golgi</td> <td>SLC35A2-CDG (EIEE22)</td> <td>XL</td> <td>23561849</td> </tr> <tr> <td class="indent1">Solute carrier family 35 member A3 (<em>SLC35A3</em>)</td> <td>605632</td> <td>UDP-GlcNAc transport</td> <td>Golgi</td> <td>SLC35A3-CDG</td> <td>AR</td> <td>24031089</td> </tr> <tr> <td class="indent1">Solute carrier family 35 member C1 (<em>SLC35C1</em>)</td> <td>605881</td> <td>GDP-fucose transport</td> <td>Golgi</td> <td>SLC35C1-CDG (CDG-IIc)</td> <td>AR</td> <td>11326279</td> </tr> <tr> <td class="indent1">Solute carrier family 35 member D1 (<em>SLC35D1</em>)</td> <td>610804</td> <td>UDP-GlcA/UDP-GalNAc transport</td> <td>Golgi</td> <td>Schneckenbecken dysplasia</td> <td>AR</td> <td>17952091</td> </tr> <tr> <td class="indent1">Solute carrier family 39 member 8 (<em>SLC39A8</em>)</td> <td>608732</td> <td>Cation transporter</td> <td>Plasma membrane</td> <td>SLC39A8-CDG (CDG-IIn)</td> <td>AR</td> <td>26637978, 26637979</td> </tr> <tr> <td class="subtitle2_left" colspan="7">Vesicular trafficking</td> </tr> <tr> <td class="indent1">Component of oligomeric Golgi complex 1 (<em>COG1</em>)</td> <td>606973</td> <td>Golgi-to-ER retrograde transport</td> <td>Vesicular membrane/cytosol</td> <td>COG1-CDG (CDG-IIg)</td> <td>AR</td> <td>16537452</td> </tr> <tr> <td class="indent1">Component of oligomeric Golgi complex 2 (<em>COG2</em>)</td> <td>606974</td> <td>Golgi-to-ER retrograde transport</td> <td>Vesicular membrane/cytosol</td> <td>COG2-CDG (CDG-IIq)</td> <td>AR</td> <td>24784932</td> </tr> <tr> <td class="indent1">Component of oligomeric Golgi complex 4 (<em>COG4</em>)</td> <td>606976</td> <td>Golgi-to-ER retrograde transport</td> <td>Vesicular membrane/cytosol</td> <td>COG4-CDG (CDG-IIj, AR), Saul-Wilson syndrome (AD)</td> <td>AR, AD</td> <td>19494034</td> </tr> <tr> <td class="indent1">Component of oligomeric Golgi complex 5 (<em>COG5</em>)</td> <td>606821</td> <td>Golgi-to-ER retrograde transport</td> <td>Vesicular membrane/cytosol</td> <td>COG5-CDG (CDG-IIi)</td> <td>AR</td> <td>19690088</td> </tr> <tr> <td class="indent1">Component of oligomeric Golgi complex 6 (<em>COG6</em>)</td> <td>606977</td> <td>Golgi-to-ER retrograde transport</td> <td>Vesicular membrane/cytosol</td> <td>COG6-CDG (CDG IIL), Shaheen syndrome</td> <td>AR</td> <td>20605848</td> </tr> <tr> <td class="indent1">Component of oligomeric Golgi complex 7 (<em>COG7</em>)</td> <td>606978</td> <td>Golgi-to-ER retrograde transport</td> <td>Vesicular membrane/cytosol</td> <td>COG7-CDG (CDG-IIe)</td> <td>AR</td> <td>15107842</td> </tr> <tr> <td class="indent1">Component of oligomeric Golgi complex 8 (<em>COG8</em>)</td> <td>606979</td> <td>Golgi-to-ER retrograde transport</td> <td>Vesicular membrane/cytosol</td> <td>COG8-CDG (CDG-IIh)</td> <td>AR</td> <td>17220172</td> </tr> <tr> <td class="indent1">COPI coat complex subunit alpha (<em>COPA</em>)</td> <td>601924</td> <td>COP-I subunit alpha (Golgi-to-ER transport)</td> <td>Vesicular membrane/cytosol</td> <td>Autoimmune interstitial lung, joint, and kidney disease</td> <td>AD</td> <td>25894502</td> </tr> <tr> <td class="indent1">COPI coat complex subunit beta 2 (<em>COPB2</em>)</td> <td>606990</td> <td>COP-I subunit beta-2 (Golgi-to-ER transport)</td> <td>Vesicular membrane/cytosol</td> <td>Primary microcephaly</td> <td>AR</td> <td>29036432</td> </tr> <tr> <td class="indent1">Archain 1 (<em>ARCN1</em>)</td> <td>600820</td> <td>COP-I subunit delta (Golgi-to-ER transport)</td> <td>Vesicular membrane/cytosol</td> <td>Rhizomelic short stature with microcephaly, micrognathia, and developmental delay</td> <td>AD</td> <td>27476655</td> </tr> <tr> <td class="indent1">Sec23 homolog A, COPII coat complex component (<em>SEC23A</em>)</td> <td>610511</td> <td>COPII component (ER-to-Golgi transport)</td> <td>Vesicular membrane/cytosol</td> <td>Craniolenticulosutural dysplasia (Boyadjiev-Jabs syndrome)</td> <td>AR</td> <td>16980979</td> </tr> <tr> <td class="indent1">SEC23 homolog B, COPII coat complex component (<em>SEC23B</em>)</td> <td>610512</td> <td>COPII component (ER-to-Golgi transport)</td> <td>Vesicular membrane/cytosol</td> <td>Congenital dyserythropoietic anemia type II; Cowden syndrome 7</td> <td>AR, AD</td> <td>19561605, 19621418, 26522472</td> </tr> <tr> <td class="indent1">SEC24 homolog D, COPII coat complex component (<em>SEC24D</em>)</td> <td>607186</td> <td>COPII component (ER-to-Golgi transport)</td> <td>Vesicular membrane/cytosol</td> <td>Cole-Carpenter syndrome 2</td> <td>AR</td> <td>25683121</td> </tr> <tr> <td class="indent1">Secretion-associated Ras-related GTPase 1B (<em>SAR1B</em>)</td> <td>607690</td> <td>COPII GTPase (ER-to-Golgi transport)</td> <td>Vesicular membrane/cytosol</td> <td>Chylomicron retention disease</td> <td>AR</td> <td>12692552</td> </tr> <tr> <td class="indent1">Thyroid hormone receptor interactor 11 (<em>TRIP11</em>)</td> <td>604505</td> <td>Anterograde and retrograde transport</td> <td>cis-Golgi</td> <td>Achondrogenesis IA; odontochondrodysplasia</td> <td>AR</td> <td>20089971</td> </tr> <tr> <td class="indent1">Trafficking protein particle complex 2 (<em>TRAPPC2</em>)</td> <td>300202</td> <td>Subunit of TRAPP tethering complex</td> <td>Vesicular membrane/cytosol</td> <td>SED tarda</td> <td>XL</td> <td>10431248</td> </tr> <tr> <td class="indent1">Trafficking protein particle complex 2 like (<em>TRAPPC2L</em>)</td> <td>610970</td> <td>Subunit of TRAPP tethering complex</td> <td>Vesicular membrane/cytosol</td> <td>TRAPPC2L-CDG</td> <td>AR</td> <td>31020216</td> </tr> <tr> <td class="indent1">Trafficking protein particle complex 4 (<em>TRAPPC4</em>)</td> <td>610971</td> <td>Subunit of TRAPP tethering complex</td> <td>Vesicular membrane/cytosol</td> <td>TRAPPC4-CDG</td> <td>AR</td> <td>31794024</td> </tr> <tr> <td class="indent1">Trafficking protein particle complex 6B (<em>TRAPPC6B</em>)</td> <td>610397</td> <td>Subunit of TRAPP tethering complex</td> <td>Vesicular membrane/cytosol</td> <td>TRAPPC8B-CDG</td> <td>AR</td> <td>28626029</td> </tr> <tr> <td class="indent1">Trafficking protein particle complex 9 (<em>TRAPPC9</em>)</td> <td>611966</td> <td>Subunit of TRAPP tethering complex</td> <td>Vesicular membrane/cytosol</td> <td>MRT13</td> <td>AR</td> <td>20004763, 20004764, 20004765</td> </tr> <tr> <td class="indent1">Trafficking protein particle complex 11 (<em>TRAPPC11</em>)</td> <td>614138</td> <td>Subunit of TRAPP tethering complex</td> <td>Vesicular membrane/cytosol</td> <td>LGMD2S</td> <td>AR</td> <td>23830518</td> </tr> <tr> <td class="indent1">Trafficking protein particle complex 12 (<em>TRAPPC12</em>)</td> <td>614139</td> <td>Subunit of TRAPP tethering complex</td> <td>Vesicular membrane/cytosol</td> <td>TRAPPC12-CDG</td> <td>AR</td> <td>28777934</td> </tr> <tr> <td class="indent1">Golgi SNAP receptor complex member 2 (<em>GOSR2</em>)</td> <td>604027</td> <td>Subunit of SNARE family of vesicle docking proteins</td> <td>Vesicular membrane/cytosol</td> <td>GOSR2-CDG</td> <td>AR</td> <td>21549339</td> </tr> <tr> <td class="subtitle2_left" colspan="7">Golgi homeostasis</td> </tr> <tr> <td class="indent1">ATPase H+ transporting V0 subunit a2 (<em>ATP6V0A2</em>)</td> <td>611716</td> <td>pH (subunit of vacuolar ATPase)</td> <td>Vacuolar membrane</td> <td>AR cutis laxa type IIA (wrinkly skin syndrome)</td> <td>AR</td> <td>18157129</td> </tr> <tr> <td class="indent1">ATPase H+ transporting accessory protein 1 (<em>ATP6AP1</em>)</td> <td>300197</td> <td>pH (subunit of vacuolar ATPase)</td> <td>Vacuolar membrane</td> <td>Immunodeficiency 47</td> <td>XL</td> <td>27231034</td> </tr> <tr> <td class="indent1">ATPase H+ transporting accessory protein 2 (<em>ATP6AP2</em>)</td> <td>300556</td> <td>pH (subunit of vacuolar ATPase)</td> <td>Vacuolar membrane</td> <td>X-linked intellectual disability, Hedera type</td> <td>XL</td> <td>15746149</td> </tr> <tr> <td class="indent1">ATPase H+ transporting V1 subunit A (<em>ATP6V1A</em>)</td> <td>607027</td> <td>pH (subunit of vacuolar ATPase)</td> <td>Vacuolar membrane</td> <td>AR cutis laxa type IID</td> <td>AR</td> <td>28065471</td> </tr> <tr> <td class="indent1">ATPase H+ transporting V1 subunit E1 (<em>ATP6V1E1</em>)</td> <td>108746</td> <td>pH (subunit of vacuolar ATPase)</td> <td>Vacuolar membrane</td> <td>AR cutis laxa type IIC</td> <td>AR</td> <td>28065471</td> </tr> <tr> <td class="indent1">Transmembrane protein 199 (<em>TMEM199</em>)</td> <td>616815</td> <td>Assembly factor for vacuolar ATPase</td> <td>Vacuolar membrane</td> <td>TMEM199-CDG (CDG-IIp)</td> <td>AR</td> <td>26833330</td> </tr> <tr> <td class="indent1">Coiled-coil domain containing 115 (<em>CCDC115</em>)</td> <td>613734</td> <td>Assembly factor for vacuolar ATPase</td> <td>Vacuolar membrane</td> <td>CCDC115-CDG (CDG-Ip)</td> <td>AR</td> <td>26833332</td> </tr> <tr> <td class="indent1">Vacuolar ATPase assembly factor VMA21 (<em>VMA21</em>)</td> <td>300913</td> <td>Assembly factor for vacuolar ATPase</td> <td>Vacuolar membrane</td> <td>X-linked myopathy with excessive autophagy</td> <td>XL</td> <td>23315026</td> </tr> <tr> <td class="indent1">Transmembrane protein 165 (<em>TMEM165</em>)</td> <td>614726</td> <td>pH, manganese and calcium homeostasis</td> <td>Golgi</td> <td>TMEM165-CDG (CDG-IIk)</td> <td>AR</td> <td>22683087</td> </tr> <tr> <td class="indent1">Solute carrier family 9 member A7 (<em>SLC9A7</em>)</td> <td>300368</td> <td>Cation-proton exchanger</td> <td>Golgi</td> <td>SLC9A7-CDG</td> <td>XL</td> <td>30335141</td> </tr> <tr> <td class="subtitle2_left" colspan="7">Unknown</td> </tr> <tr> <td class="indent1">TDP-glucose 4,6-dehydratase (<em>TGDS</em>)</td> <td>616146</td> <td>TDP-Glc 4,6-dehydratase</td> <td>Unknown</td> <td>Catel-Manzke syndrome</td> <td>AR</td> <td>25480037</td> </tr> </tbody></table></div><div class="graphic_footnotes">AD: autosomal dominant; AR: autosomal recessive; CDG: congenital disorder of glycosylation; CMS: congenital myasthenic syndrome; EIEE: early infantile epileptic encephalopathy; ER: endoplasmic reticulum; F6P: fructose 6-phosphate; GlcNAc: N-acetylglucosamine; GTP: guanosine triphosphate; LGMD: limb-girdle muscular dystrophy; ManNAc: N-acetyl-D-mannosamine; MDDG: muscular dystrophy-dystroglycanopathy; MRT: intellectual disability; Neu5Ac-9P: N-acylneuraminate 9 phosphate; SED: spondyloepiphyseal dysplasia; SEMD: spondyloepimetaphyseal dysplasia; Sia: sialic acid; TRAPP: transport protein particle; UDP: uridine diphosphate; XL: X linked.</div><div class="graphic_reference">Adapted from: Ferreira CR, Altassan R, Marques-Da-Silva D, et al. Recognizable phenotypes in CDG. J Inherit Metab Dis 2018; 41:541.</div><div id="graphicVersion">Graphic 140155 Version 1.0</div></div></div>
</div>
</div>

</section>

</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->


<!-- End Footer Area -->
<!-- Back to top -->

<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->

<!-- Prpper JS -->

<!-- Bootstrap Min JS -->

<!-- Classy Nav Min Js -->

<!-- Owl Carousel Min Js -->

<!-- Magnific Popup JS -->

<!-- CounterUp JS -->

<!-- Waypoints JS -->

<!-- Form Validator Min JS -->

<!-- Contact Form Min JS -->

<!-- Main JS -->

<!-- Global site tag (gtag.js) - Google Analytics -->






</body>
</html>
